By Dr. Joseph Mechak A new preventative medication for RSV! Last year we gained a fantastic new tool that helps prevent hospitalizations and deaths related to the Respiratory Syncytial Virus (RSV). Nirsevimab (Beyfortus) is a monoclonal antibody targeted against RSV that received both FDA approval and a CDC recommendation in 2023. We are SO
Read more
By: Dr. Leah Pedoeim School is back in session, and believe it or not, winter is just around the corner – bringing with it the promise of snow days, hot chocolate, and unfortunately, respiratory viruses. While the flu may feel like old news in the post-pandemic landscape, the truth is that the flu is
Read more
By: Dr. Joseph Mechak Over the past few weeks we gained a new tool to help prevent hospitalizations and deaths related to the Respiratory Syncytial Virus (RSV). Nirsevimab (Beyfortus) is a monoclonal antibody targeted against RSV that received both FDA approval and a CDC recommendation over the past few weeks. We are SO excited
Read more
By: Dr. Joseph Mechak This year’s respiratory viral season has been unlike any other in recent memory. A few things that have set this respiratory season apart are that it was: Early – Many viruses, but Flu and RSV in particular, came earlier than usual this year. RSV season is classically from December to March,
Read more15204 Omega Drive 301-279-6750
Suite #100 301-208-8953
Rockville, MD 20850
© 2025 Potomac Pediatrics | All rights reserved | SITEMAP | Privacy Policy
15204 Omega Drive Suite #100 Rockville, MD 20850
Phone: 301-279-6750 | Fax: (301)-208-8953
Website Design by COGO Interactive
Most Commented